Cargando…

Collaborative Heart Attack Management Program (CHAMP): use of prehospital thrombolytics to improve timeliness of STEMI management in British Columbia

Coronary artery disease is the second leading cause of death in Canada. Time to treatment in ST-elevation myocardial infarction (STEMI) is directly related to morbidity and mortality. Thrombolysis is the primary treatment for STEMI in many regions of Canada because of prolonged transport times to pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Guy, Andrew, Gabers, Nicki, Crisfield, Chase, Helmer, Jennie, Peterson, Shaylee C, Ganstal, Anders, Harper, Caryl, Gibson, Ross, Dhesi, Sumandeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650474/
https://www.ncbi.nlm.nih.gov/pubmed/34872989
http://dx.doi.org/10.1136/bmjoq-2021-001519
_version_ 1784611204076929024
author Guy, Andrew
Gabers, Nicki
Crisfield, Chase
Helmer, Jennie
Peterson, Shaylee C
Ganstal, Anders
Harper, Caryl
Gibson, Ross
Dhesi, Sumandeep
author_facet Guy, Andrew
Gabers, Nicki
Crisfield, Chase
Helmer, Jennie
Peterson, Shaylee C
Ganstal, Anders
Harper, Caryl
Gibson, Ross
Dhesi, Sumandeep
author_sort Guy, Andrew
collection PubMed
description Coronary artery disease is the second leading cause of death in Canada. Time to treatment in ST-elevation myocardial infarction (STEMI) is directly related to morbidity and mortality. Thrombolysis is the primary treatment for STEMI in many regions of Canada because of prolonged transport times to percutaneous coronary intervention-capable centres. To reduce time from first medical contact (FMC) to thrombolysis, some emergency medical services (EMS) systems have implemented prehospital thrombolysis (PHT). PHT is not a novel concept and has a strong evidence base showing reduced mortality. Here, we describe a quality improvement initiative to decrease time from FMC to thrombolysis using PHT and aim to describe our methods and challenges during implementation. We used a quality improvement framework to collaborate with hospitals, EMS, cardiology, emergency medicine and other stakeholders during implementation. We trained advanced care paramedics to administer thrombolysis in STEMI with remote cardiologist support and aimed to achieve a guideline-recommended median FMC to needle time of <30 min in 80% of patients. Overall, we reduced our median FMC to needle time by 70%. Our baseline patients undergoing in-hospital thrombolysis had a median time of 84 min (IQR 62–116 min), while patients after implementation of PHT had a median time of 25 min (IQR 23–39 min). Patients treated within the guideline-recommended time from FMC to needle of <30 min increased from 0% at baseline to 61% with PHT. Return on investment analysis showed $2.80 saved in acute care costs for every $1.00 spent on the intervention. While we did not achieve our goal of 80% compliance with FMC to needle time of <30 min, our results show that the intervention substantially reduced the FMC to needle time and overall cost. We plan to continue with ongoing implementation of PHT through expansion to other communities in our province.
format Online
Article
Text
id pubmed-8650474
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-86504742021-12-22 Collaborative Heart Attack Management Program (CHAMP): use of prehospital thrombolytics to improve timeliness of STEMI management in British Columbia Guy, Andrew Gabers, Nicki Crisfield, Chase Helmer, Jennie Peterson, Shaylee C Ganstal, Anders Harper, Caryl Gibson, Ross Dhesi, Sumandeep BMJ Open Qual Quality Improvement Report Coronary artery disease is the second leading cause of death in Canada. Time to treatment in ST-elevation myocardial infarction (STEMI) is directly related to morbidity and mortality. Thrombolysis is the primary treatment for STEMI in many regions of Canada because of prolonged transport times to percutaneous coronary intervention-capable centres. To reduce time from first medical contact (FMC) to thrombolysis, some emergency medical services (EMS) systems have implemented prehospital thrombolysis (PHT). PHT is not a novel concept and has a strong evidence base showing reduced mortality. Here, we describe a quality improvement initiative to decrease time from FMC to thrombolysis using PHT and aim to describe our methods and challenges during implementation. We used a quality improvement framework to collaborate with hospitals, EMS, cardiology, emergency medicine and other stakeholders during implementation. We trained advanced care paramedics to administer thrombolysis in STEMI with remote cardiologist support and aimed to achieve a guideline-recommended median FMC to needle time of <30 min in 80% of patients. Overall, we reduced our median FMC to needle time by 70%. Our baseline patients undergoing in-hospital thrombolysis had a median time of 84 min (IQR 62–116 min), while patients after implementation of PHT had a median time of 25 min (IQR 23–39 min). Patients treated within the guideline-recommended time from FMC to needle of <30 min increased from 0% at baseline to 61% with PHT. Return on investment analysis showed $2.80 saved in acute care costs for every $1.00 spent on the intervention. While we did not achieve our goal of 80% compliance with FMC to needle time of <30 min, our results show that the intervention substantially reduced the FMC to needle time and overall cost. We plan to continue with ongoing implementation of PHT through expansion to other communities in our province. BMJ Publishing Group 2021-12-06 /pmc/articles/PMC8650474/ /pubmed/34872989 http://dx.doi.org/10.1136/bmjoq-2021-001519 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Quality Improvement Report
Guy, Andrew
Gabers, Nicki
Crisfield, Chase
Helmer, Jennie
Peterson, Shaylee C
Ganstal, Anders
Harper, Caryl
Gibson, Ross
Dhesi, Sumandeep
Collaborative Heart Attack Management Program (CHAMP): use of prehospital thrombolytics to improve timeliness of STEMI management in British Columbia
title Collaborative Heart Attack Management Program (CHAMP): use of prehospital thrombolytics to improve timeliness of STEMI management in British Columbia
title_full Collaborative Heart Attack Management Program (CHAMP): use of prehospital thrombolytics to improve timeliness of STEMI management in British Columbia
title_fullStr Collaborative Heart Attack Management Program (CHAMP): use of prehospital thrombolytics to improve timeliness of STEMI management in British Columbia
title_full_unstemmed Collaborative Heart Attack Management Program (CHAMP): use of prehospital thrombolytics to improve timeliness of STEMI management in British Columbia
title_short Collaborative Heart Attack Management Program (CHAMP): use of prehospital thrombolytics to improve timeliness of STEMI management in British Columbia
title_sort collaborative heart attack management program (champ): use of prehospital thrombolytics to improve timeliness of stemi management in british columbia
topic Quality Improvement Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650474/
https://www.ncbi.nlm.nih.gov/pubmed/34872989
http://dx.doi.org/10.1136/bmjoq-2021-001519
work_keys_str_mv AT guyandrew collaborativeheartattackmanagementprogramchampuseofprehospitalthrombolyticstoimprovetimelinessofstemimanagementinbritishcolumbia
AT gabersnicki collaborativeheartattackmanagementprogramchampuseofprehospitalthrombolyticstoimprovetimelinessofstemimanagementinbritishcolumbia
AT crisfieldchase collaborativeheartattackmanagementprogramchampuseofprehospitalthrombolyticstoimprovetimelinessofstemimanagementinbritishcolumbia
AT helmerjennie collaborativeheartattackmanagementprogramchampuseofprehospitalthrombolyticstoimprovetimelinessofstemimanagementinbritishcolumbia
AT petersonshayleec collaborativeheartattackmanagementprogramchampuseofprehospitalthrombolyticstoimprovetimelinessofstemimanagementinbritishcolumbia
AT ganstalanders collaborativeheartattackmanagementprogramchampuseofprehospitalthrombolyticstoimprovetimelinessofstemimanagementinbritishcolumbia
AT harpercaryl collaborativeheartattackmanagementprogramchampuseofprehospitalthrombolyticstoimprovetimelinessofstemimanagementinbritishcolumbia
AT gibsonross collaborativeheartattackmanagementprogramchampuseofprehospitalthrombolyticstoimprovetimelinessofstemimanagementinbritishcolumbia
AT dhesisumandeep collaborativeheartattackmanagementprogramchampuseofprehospitalthrombolyticstoimprovetimelinessofstemimanagementinbritishcolumbia